Arvind Gulbake
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 11
- Advancements in Transdermal Drug Delivery 7
- Drug Solubulity and Delivery Systems 4
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 18
- Co-authors
- Sanjay Jain (25 shared papers)Satish Shilpi (13 shared papers)Pooja Hurkat (10 shared papers)Shivaji Kashte (3 shared papers)Saadiq F. El‐Amin (1 shared paper)Ashish S. Jain (6 shared papers)Ashim Gupta (1 shared paper)Aviral Jain (18 shared papers)
In The Last Decade
Arvind Gulbake
54 papers receiving 1.6k citations
Arvind Gulbake's Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmaceutical Science 500
- Biomaterials 484
- Molecular Medicine 103
- Health 92
- Infectious Diseases 157
Countries citing papers authored by Arvind Gulbake
This map shows the geographic impact of Arvind Gulbake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Gulbake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Gulbake more than expected).
Fields of papers citing papers by Arvind Gulbake
This network shows the impact of papers produced by Arvind Gulbake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Gulbake. The network helps show where Arvind Gulbake may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind Gulbake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 vaccines: rapid development, implications, challenges and future prospects Hit paper breakdown → | 2021 | 278 |
| 2 | 2015 | 143 | |
| 3 | 2016 | 132 | |
| 4 | 2013 | 130 | |
| 5 | 2010 | 103 | |
| 6 | 2013 | 99 | |
| 7 | 2012 | 75 | |
| 8 | 2015 | 53 | |
| 9 | 2012 | 51 | |
| 10 | 2021 | 41 | |
| 11 | 2013 | 37 | |
| 12 | 2013 | 34 | |
| 13 | 2013 | 34 | |
| 14 | 2011 | 34 | |
| 15 | 2012 | 30 | |
| 16 | 2010 | 30 | |
| 17 | 2010 | 29 | |
| 18 | 2009 | 26 | |
| 19 | 2010 | 24 | |
| 20 | 2024 | 24 |
About Arvind Gulbake
Arvind Gulbake is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Biomedical Engineering and Food Science, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (18 papers), RNA Interference and Gene Delivery (13 papers), Advanced Drug Delivery Systems (11 papers), Advancements in Transdermal Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers), Graphene and Nanomaterials Applications (5 papers), Essential Oils and Antimicrobial Activity (5 papers) and Drug Solubulity and Delivery Systems (4 papers). The work is most often cited by research in Pharmaceutical Science (500 citations), Biomaterials (484 citations), Molecular Medicine (103 citations), Health (92 citations) and Infectious Diseases (157 citations). Arvind Gulbake has collaborated with scholars based in India, Finland and Germany. Frequent co-authors include Sanjay Jain, Satish Shilpi, Pooja Hurkat, Shivaji Kashte, Saadiq F. El‐Amin, Ashish S. Jain, Ashim Gupta, Aviral Jain, Ankit K. Jain and Piush Khare. Their work appears in journals such as Critical Reviews in Therapeutic Drug Carrier Systems, Journal of Microencapsulation, Drug Delivery, Journal of Nanoparticle Research and International Journal of Applied Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.